AUS
NZ
UK
CA
USA
IND
Healthcare
HCA Healthcare (NYSE:HCA) Shares Little Changed in NYSE Trade
December 18, 2025 08:53 AM PST| By Anmol KhazanchiDetailed discussion of HCA Healthcare operations, service scope, regulatory environment, workforce structure, and market classification references within the S&P 500 healthcare landscape.
Charles River Labs (NYSE:CRL) Shares Little Changed in NYSE Trade
December 18, 2025 06:32 AM PST| By Anmol KhazanchiDetailed examination of Charles River Laboratories International activities, service segments, geographic presence, and contextual positioning within the life sciences services sector and major market indexes.
Edwards Lifesciences (NYSE:EW) Shares Little Changed in NYSE Session
December 18, 2025 06:14 AM PST| By Anmol KhazanchiDetailed review of Edwards Lifesciences in the healthcare devices sector, outlining product focus, operational structure, geographic reach, and placement within the NYSE Composite framework.
Sagimet Biosciences (Nasdaq:SGMT) Secures Global License for Resmetirom API in Combination Program
December 18, 2025 02:18 AM PST| By Team Kalkine MediaHighlights,Sagimet Biosciences has entered into a global, exclusive license agreement with TAPI covering resmetirom API intellectual property.,The agreement supports technical evaluation, manufacturing, and potential development of a fixed-dose combi...
Day One Biopharmaceuticals (NASDAQ:DAWN) Gains Visibility Nasdaq Today
December 18, 2025 12:00 AM PST| By Anmol KhazanchiDay One Biopharmaceuticals (NASDAQ:DAWN) focuses on targeted oncology therapies for genomically defined cancers, remaining visible in biotechnology discussions shaped by developments tracked across nasdaq today.
Illumina Inc (NASDAQ:ILMN) Nasdaq Futures Shape Discovery Market Now
December 18, 2025 12:00 AM PST| By Anmol KhazanchiIllumina (NASDAQ:ILMN) advances global genomic research through sequencing technologies, remaining central to life sciences discussions that intersect with broader market narratives linked to nasdaq futures.
CVS Health Corporation (NYSE:CVS) Russell 1000 Integrated Care Role
December 18, 2025 12:00 AM PST| By Anmol KhazanchiCVS Health (NYSE:CVS) delivers integrated healthcare services across insurance, pharmacy, and consumer wellness, maintaining visibility among large healthcare providers classified within the Russell 1000 ETF.
Merck & Co Inc (NYSE:MRK) S&P 500 Futures Healthcare Scale Research
December 18, 2025 12:00 AM PST| By Anmol KhazanchiMerck & Co. (NYSE:MRK) operates across human and animal health segments, with corporate updates often viewed within broader market discussions shaped by s&p 500 futures.
Understanding recent coverage of Koninklijke Philips within healthcare technology
December 17, 2025 05:11 PM PST| By Anmol KhazanchiAn objective examination of recent descriptive coverage surrounding Koninklijke Philips, highlighting healthcare technology operations, market context, and institutional ownership themes without subjective or transactional language.
Boston Scientific (NYSE:BSX) Shares Rise After Strong Device Demand
December 17, 2025 07:53 AM PST| By Anmol KhazanchiBoston Scientific (NYSE:BSX) offers medical devices across multiple specialties, integrating advanced technology and software solutions to support healthcare providers globally.
Haemonetics Expands Medical Solutions Across Global Healthcare
December 17, 2025 07:28 AM PST| By Anmol KhazanchiHaemonetics (NYSE:HAE) provides advanced plasma collection systems, donor management software, and global healthcare solutions, integrating technology for efficient clinical operations and patient care.
Integra LifeSciences Holdings (NASDAQ:IART) Nasdaq Index Procedural Tools
December 17, 2025 12:00 AM PST| By Anmol KhazanchiIntegra LifeSciences (NASDAQ:IART) supports neurosurgery and advanced wound care through specialised medical devices, maintaining visibility within the nasdaq index alongside healthcare-focused technology providers.
CureVac N.V. (NASDAQ:CVAC) Nasdaq Composite Tracks Biotech Momentum
December 17, 2025 12:00 AM PST| By Anmol KhazanchiCureVac (NASDAQ:CVAC) develops mRNA-based vaccines targeting infectious diseases, strengthening its scientific presence as healthcare innovation remains visible within the nasdaq composite.
Prothena Corp (NASDAQ:PRTA) Nasdaq Today Focuses on Protein Biology
December 17, 2025 12:00 AM PST| By Anmol KhazanchiProthena Corporation plc (NASDAQ:PRTA) advances clinical-stage protein-focused therapies for neurological and systemic diseases, remaining visible within biotechnology coverage associated with nasdaq today.
Recursion Pharmaceuticals (NASDAQ:RXRX) Nasdaq Index Fund Spotlight
December 17, 2025 12:00 AM PST| By Anmol KhazanchiRecursion Pharmaceuticals (NASDAQ:RXRX) applies automation and data science to large-scale drug discovery, positioning its platform-based model among biotechnology firms represented within the nasdaq index fund.
Roivant Sciences Ltd (NASDAQ:ROIV) Nasdaq Futures Pharma Platform
December 17, 2025 12:00 AM PST| By Anmol KhazanchiRoivant Sciences (NASDAQ:ROIV) expands its Vant-based biopharmaceutical platform, supporting diversified therapeutic development and research-driven innovation, while remaining visible alongside trends reflected in nasdaq futures.
Catalyst Pharmaceuticals (NASDAQ:CPRX) Nasdaq Index Clinical Depth
December 17, 2025 12:00 AM PST| By Anmol KhazanchiHighlights,Catalyst Pharmaceuticals advances therapies for rare neurological conditions,Focused commercial portfolio supports specialised patient populations,Research-driven structure strengthens long-term development pathways,Catalyst Pharmaceutical...
Masimo Corporation (NASDAQ:MASI) Nasdaq Composite Health Analytics
December 17, 2025 12:00 AM PST| By Anmol KhazanchiMasimo Corporation (NASDAQ:MASI) advances noninvasive patient monitoring through accurate, connected clinical technologies, maintaining visibility within healthcare-focused activity across the nasdaq composite.
Kodiak Sciences Inc (NASDAQ:KOD) Advances Retinal Biologic Research
December 17, 2025 12:00 AM PST| By Anmol KhazanchiKodiak Sciences Inc operates as a clinical-stage biopharmaceutical company developing biologic therapies for retinal diseases, with research programs centered on chronic and progressive vision-related conditions.
DBV Technologies (NASDAQ:DBVT) Builds Long-Term Clinical Direction
December 17, 2025 12:00 AM PST| By Anmol KhazanchiDBV Technologies is a clinical-stage biopharmaceutical company developing epicutaneous immunotherapy platforms focused on food allergies, emphasizing noninvasive delivery, controlled dosing, and structured clinical evaluation.
